Zydus Lifesciences Licenses Cancer Drug in US
February 14, 2025 16:14
Zydus Lifesciences subsidiary has partnered with Zhuhai Beihai Biotech to market a cancer drug, Beizray (Albumin Solubilized Docetaxel injection), in the US. The drug is indicated for various...